- Home
- SILO vs QNRX Comparison
SILO vs QNRX Comparison
Compare SILO & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- QNRX
- Stock Information
- Founded
- SILO 2010
- QNRX 2018
- Country
- SILO United States
- QNRX United States
- Employees
- SILO N/A
- QNRX N/A
- Industry
- SILO Apparel
- QNRX Medical/Dental Instruments
- Sector
- SILO Consumer Discretionary
- QNRX Health Care
- Exchange
- SILO Nasdaq
- QNRX Nasdaq
- Market Cap
- SILO 5.9M
- QNRX 4.8M
- IPO Year
- SILO N/A
- QNRX N/A
- Fundamental
- Price
- SILO $0.70
- QNRX $8.00
- Analyst Decision
- SILO
- QNRX
- Analyst Count
- SILO 0
- QNRX 0
- Target Price
- SILO N/A
- QNRX N/A
- AVG Volume (30 Days)
- SILO 948.9K
- QNRX 111.7K
- Earning Date
- SILO 11-11-2025
- QNRX 11-06-2025
- Dividend Yield
- SILO N/A
- QNRX N/A
- EPS Growth
- SILO N/A
- QNRX N/A
- EPS
- SILO N/A
- QNRX N/A
- Revenue
- SILO $72,102.00
- QNRX N/A
- Revenue This Year
- SILO $1.86
- QNRX N/A
- Revenue Next Year
- SILO N/A
- QNRX N/A
- P/E Ratio
- SILO N/A
- QNRX N/A
- Revenue Growth
- SILO N/A
- QNRX N/A
- 52 Week Low
- SILO $0.41
- QNRX $5.01
- 52 Week High
- SILO $3.37
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- SILO 53.25
- QNRX 56.05
- Support Level
- SILO $0.58
- QNRX $7.35
- Resistance Level
- SILO $0.83
- QNRX $10.00
- Average True Range (ATR)
- SILO 0.05
- QNRX 0.43
- MACD
- SILO 0.01
- QNRX 0.11
- Stochastic Oscillator
- SILO 45.56
- QNRX 24.53
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.